CD168 Polyclonal Antibody

The hyaluronan mediated motility receptor encoded by HMMR is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.

The CD168 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CD168 protein expression in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human CD168 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards CD168 protein, making it an ideal tool for various research applications.

The CD168 Polyclonal Antibody is suitable for use in a variety of immunoassays, including Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in human, mouse, and rat samples, and has been shown to detect CD168 protein expression in a variety of tissues and cell types. This antibody is supplied as a liquid formulation in phosphate-buffered saline (PBS) with 0.02% sodium azide as a preservative.

The CD168 Polyclonal Antibody is a valuable tool for researchers studying the role of CD168 protein in various biological processes, including cell adhesion, migration, and invasion. It can be used to investigate the expression and localization of CD168 protein in normal and diseased tissues, as well as to study the effects of CD168 protein modulation on cellular behavior. With its high sensitivity and specificity, the CD168 Polyclonal Antibody is an essential reagent for any researcher interested in studying CD168 protein expression and function.